Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial
Anne R Cappola, Emily R Schriver, Danielle L Mowery, Colin Wollack, Camelot T Ives, Ryan Gonzales, Joseph N Cappella, Anne R Cappola, Emily R Schriver, Danielle L Mowery, Colin Wollack, Camelot T Ives, Ryan Gonzales, Joseph N Cappella
Abstract
This randomized clinical trial assess whether targeted messaging could improve the return to in-person visits during the COVID-19 pandemic.
Trial registration: ClinicalTrials.gov NCT04418947.
Conflict of interest statement
Conflict of Interest Disclosures: None reported.
Figures
References
- Czeisler MÉ, Marynak K, Clarke KEN, et al. . Delay or avoidance of medical care because of COVID-19–related concerns—United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250-1257. doi:10.15585/mmwr.mm6936a4
- Findling MG, Blendon RJ, Benson JM. Delayed care with harmful health consequences—reported experiences from national surveys during coronavirus disease 2019. JAMA Health Forum. Published online December 14, 2020.
- Jeffery MM, D’Onofrio G, Paek H, et al. . Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US. JAMA Intern Med. 2020;180(10):1328-1333. doi:10.1001/jamainternmed.2020.3288
- ReviveHealth . COVID-19 Consumer Survey Update, April 2020. Accessed September 20, 2020.
- Fishbein M, Cappella JN. The role of theory in developing effective health communications. J Commun. 2006. Aug 1;56:S1–17. doi:10.1111/j.1460-2466.2006.00280.x
- Lee SJ, Brennan E, Gibson LA, et al. . Predictive validity of an empirical approach for selecting promising message topics: a randomized-controlled study. J Commun. 2016;66(3):433-453. doi:10.1111/jcom.12227
Source: PubMed